Close Menu

NEW YORK (GenomeWeb) – JP Morgan today initiated coverage of Natera with a Neutral rating and a December 2019 price target of $26.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.